Psyence Group Inc
Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the h… Read more
Market Cap & Net Worth: Psyence Group Inc (PSYGF)
Psyence Group Inc (PINK:PSYGF) has a market capitalization of $71.94K ($71.94K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #41709 globally and #13566 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Psyence Group Inc's stock price $0.00 by its total outstanding shares 15638267 (15.64 Million).
Psyence Group Inc Market Cap History: 2021 to 2025
Psyence Group Inc's market capitalization history from 2021 to 2025. Data shows change from $2.24 Million to $71.94K (-65.94% CAGR).
Psyence Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Psyence Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
110.92x
Psyence Group Inc's market cap is 110.92 times its annual revenue
0.84x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $1.09 Million | $5.54K | -$4.60 Million | 197.56x | N/A |
| 2023 | $614.58K | $5.54K | -$6.08 Million | 110.92x | N/A |
Competitor Companies of PSYGF by Market Capitalization
Companies near Psyence Group Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Psyence Group Inc by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #15 globally with a market cap of $883.37 Billion USD.
- Johnson & Johnson (NYSE:JNJ): Ranked #18 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #29 globally with a market cap of $390.88 Billion USD.
- AstraZeneca PLC (NASDAQ:AZN): Ranked #46 globally with a market cap of $296.35 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15 | Eli Lilly and Company | NYSE:LLY | $883.37 Billion | $989.12 |
| #18 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $243.19 |
| #29 | AbbVie Inc | NYSE:ABBV | $390.88 Billion | $221.45 |
| #46 | AstraZeneca PLC | NASDAQ:AZN | $296.35 Billion | $192.01 |
Psyence Group Inc Historical Marketcap From 2021 to 2025
Between 2021 and today, Psyence Group Inc's market cap moved from $2.24 Million to $ 71.94K, with a yearly change of -65.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $71.94K | -68.92% |
| 2024 | $231.45K | -62.34% |
| 2023 | $614.58K | -43.86% |
| 2022 | $1.09 Million | -51.12% |
| 2021 | $2.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Psyence Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $71.94K USD |
| MoneyControl | $71.94K USD |
| MarketWatch | $71.94K USD |
| marketcap.company | $71.94K USD |
| Reuters | $71.94K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.